Lifeward Ltd. Files Definitive Proxy Statement

TL;DR

Lifeward Ltd. (fka ReWalk) filed its proxy statement. Standard governance stuff.

AI Summary

Lifeward Ltd. (formerly ReWalk Robotics Ltd.) filed a Definitive Proxy Statement (DEF 14A) on November 25, 2024. This filing is a standard proxy statement related to the company's corporate governance and shareholder matters, not detailing specific financial transactions or operational changes.

Why It Matters

This filing provides shareholders with essential information regarding upcoming votes and company governance, allowing them to make informed decisions about their investment.

Risk Assessment

Risk Level: low — This is a routine DEF 14A filing, which is standard corporate disclosure and does not inherently present new risks.

Key Numbers

• 20241125 — Filing Date (The date Lifeward Ltd. submitted its Definitive Proxy Statement.)

Key Players & Entities

• Lifeward Ltd. (company) — Filer of the DEF 14A
• ReWalk Robotics Ltd. (company) — Former name of Lifeward Ltd.
• 200 DONALD LYNCH BLVD. (location) — Business and mailing address of Lifeward Ltd.
• MARLBOROUGH, MA 01752 (location) — City, State, and ZIP of Lifeward Ltd.'s address

FAQ

Filing Documents

• zk2432379.htm (DEF 14A) — 550KB
• image00001.jpg (GRAPHIC) — 5KB
• 0001178913-24-003825.txt ( ) — 558KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 7 PROPOSAL 1 – APPROVAL OF AN AMENDMENT TO THE COMPANY'S SIXTH AMEDED AND RESTATED ARTICLES OF ASSOCIATION TO ELIMINATE THE PAR VALUE OF THE COMPANY'S ORDINARY SHARES 9 PROPOSAL 2 – APPROVAL OF THE COMPANY'S 2024 INCENTIVE COMPENSATION PLAN 10 PROPOSAL 3 – APPROVAL OF A GRANT OF EQUITY AWARDS TO LARRY JASINSKI, OUR CEO 17 OTHER BUSINESS 18 ADDITIONAL INFORMATION 18 APPENDIX A – 2024 INCENTIVE COMPENSATION PLAN A-1 200 Donald Lynch Blvd., Marlborough, MA 01752, U.S.A. Tel: +1 508.251.1154 PROXY STATEMENT This Proxy Statement is being furnished to the holders of ordinary shares, par value NIS 1.75 each, of Lifeward Ltd. ("we," the "Company", or "Lifeward") in connection with the solicitation of proxies by our Board of Directors (the "Board" or the "Board of Directors") for use at the Extraordinary General Meeting of Shareholders (the "Meeting") to be held at the Company's offices at 200 Donald Lynch Blvd., Marlborough, MA 01752, U.S.A., on Monday, December 30, 2024, at 10:00 a.m. (Eastern Standard Time) and at any adjournment or postponement thereof, pursuant to the accompanying Notice of Extraordinary General Meeting of Shareholders. We are first making available this Proxy Statement and accompanying materials to shareholders on or about November 25, 2024. The agenda of the Meeting will be as follows: 1. To amend the Company's Sixth Amended and Restated Articles of Association to eliminate the par value of the Company's ordinary shares. 2. To approve the Company's 2024 Incentive Compensation Plan. 3. To approve a grant to Larry Jasinski, the Company's Chief Executive Officer, of 14,286 restricted stock units ("RSUs") and 14,285 performance-based RSUs. 4. To act upon any other matters that may properly come before the Meeting or any adjournment or postponement thereof. Currently, we are not aware of any other matters that will come before the Meeting. If any other mat

View Full Filing

View this DEF 14A filing on SEC EDGAR